The Strange Case Of NAC: The Supplement The FDA Says Isn't One https://t.co/MWkFbjFZ9G
Why now
Thesis: Niche supplement regulatory case, low impact
Catalyst to watch: FDA ruling on NAC status
Main risk: Ruling affects only small supplement firms
Why it matters
NAC supplement regulatory dispute affects niche supplement makers but has limited market reach.
Details
The Strange Case Of NAC: The Supplement The FDA Says Isn't One https://t.co/MWkFbjFZ9G
Related assets & topics
HealthcareSources
- x · 2026-09-28 03:05 UTC